Discovery of 1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as a First-in-Class Low-Cytotoxic Nanomolar Metallo β-Lactamase Inhibitor.

Citation data:

ChemMedChem, ISSN: 1860-7187, Vol: 12, Issue: 11, Page: 845-849

Publication Year:
Usage 3
Abstract Views 3
Captures 8
Readers 8
Social Media 6
Tweets 6
Citations 1
Citation Indexes 1
Shin, Woo Shik, Bergstrom, Alexander, Bonomo, Robert A, Crowder, Michael W, Muthyala, Ramaiah, Sham, Yuk Yin
Biochemistry, Genetics and Molecular Biology, Pharmacology, Toxicology and Pharmaceutics, Chemistry
Most Recent Tweet View All Tweets
article description
VIM-2 is one of the most common carbapenem-hydrolyzing metallo β-lactamases (MBL) found in many drug-resistant Gram-negative bacterial strains. Currently, there is a lack of effective lead compounds with optimal therapeutic potential within our drug development pipeline. Here we report the discovery of 1-hydroxypyridine-2(1H)-thione-6-carboxylic acid (3) as a first-in-class metallo β-lactamase inhibitor (MBLi) with a potent inhibition K of 13 nm against VIM-2 that corresponds to a remarkable 0.99 ligand efficiency. We further established that 3 can restore the antibiotic activity of amoxicillin against VIM-2-producing E. coli in a whole cell assay with an EC of 110 nm. The potential mode of binding of 3 from molecular modeling provided structural insights that could corroborate the observed changes in the biochemical activities. Finally, 3 possesses a low cytotoxicity (CC ) of 97 μm with a corresponding therapeutic index of 880, making it a promising lead candidate for further optimization in combination antibacterial therapy.

This article has 0 Wikipedia reference.